84 related articles for article (PubMed ID: 16884837)
1. Analysis of the young and elderly variable gene repertoire in response to pneumococcal polysaccharides using a reconstituted SCID mouse model.
Shriner AK; Smithson SL; Rabquer B; Khuder S; Westerink MA
Vaccine; 2006 Nov; 24(49-50):7159-66. PubMed ID: 16884837
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the human immune response to conjugate and polysaccharide pneumococcal vaccination using a reconstituted SCID mouse model.
Shriner AK; Smithson SL; Prinz DM; Rabquer B; Khuder S; Goomber R; Westerink MA
Vaccine; 2006 Nov; 24(49-50):7197-203. PubMed ID: 16860443
[TBL] [Abstract][Full Text] [Related]
3. Blockade of CTLA-4 (CD152) enhances the murine antibody response to pneumococcal capsular polysaccharides.
Boudewijns M; Jeurissen A; Wuyts M; Moens L; Boon L; Van Neerven JJ; Kasran A; Overbergh L; Lenaerts C; Waer M; Mathieu C; Ceuppens JL; Bossuyt X
J Leukoc Biol; 2005 Nov; 78(5):1060-9. PubMed ID: 16081596
[TBL] [Abstract][Full Text] [Related]
4. Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults: analysis of the variable heavy chain repertoire.
Kolibab K; Smithson SL; Rabquer B; Khuder S; Westerink MA
Infect Immun; 2005 Nov; 73(11):7465-76. PubMed ID: 16239548
[TBL] [Abstract][Full Text] [Related]
5. Polyvalent 23 epitope polysaccharide pneumonia vaccine induced effective protection through strain-adapted effector mechanisms as demonstrated by the different cytokine responses in mice challenged with two different strains of Streptococcus pneumoniae.
Mohler J; Moine P; Azoulay-Dupuis E; Henin D; Fantin B
Eur Cytokine Netw; 2007 Mar; 18(1):23-30. PubMed ID: 17400535
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 enhances immune responses to pneumococcal polysaccharides and sheep erythrocytes in young and aged mice.
Luo W; Fine J; Garg M; Kaplan AM; Bondada S
Cell Immunol; 1999 Jul; 195(1):1-9. PubMed ID: 10433791
[TBL] [Abstract][Full Text] [Related]
7. Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults: analysis of the variable light chain repertoire.
Smithson SL; Kolibab K; Shriner AK; Srivastava N; Khuder S; Westerink MA
Infect Immun; 2005 Nov; 73(11):7477-84. PubMed ID: 16239549
[TBL] [Abstract][Full Text] [Related]
8. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.
Pletz MW; Maus U; Krug N; Welte T; Lode H
Int J Antimicrob Agents; 2008 Sep; 32(3):199-206. PubMed ID: 18378430
[TBL] [Abstract][Full Text] [Related]
10. Human antibody response to a pneumococcal vaccine in SCID-PBL-hu mice and simultaneously vaccinated human cell donors.
Aaberge IS; Steinsvik TE; Groeng EC; Leikvold RB; Løvik M
Clin Exp Immunol; 1996 Jul; 105(1):12-7. PubMed ID: 8697618
[TBL] [Abstract][Full Text] [Related]
11. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
[TBL] [Abstract][Full Text] [Related]
12. Selective defect of anti-pneumococcal IgG in a patient with persistent polyclonal B cell lymphocytosis.
Hafraoui K; Moutschen M; Smet J; Mascart F; Schaaf-Lafontaine N; Fillet G
Eur J Intern Med; 2009 May; 20(3):e62-5. PubMed ID: 19393481
[TBL] [Abstract][Full Text] [Related]
13. Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production.
Ferreira DM; Darrieux M; Oliveira ML; Leite LC; Miyaji EN
Clin Vaccine Immunol; 2008 Mar; 15(3):499-505. PubMed ID: 18184825
[TBL] [Abstract][Full Text] [Related]
14. Non-response to specific serotypes likely cause for failure to 23-valent pneumococcal polysaccharide vaccine in the elderly.
Ortqvist A; Henckaerts I; Hedlund J; Poolman J
Vaccine; 2007 Mar; 25(13):2445-50. PubMed ID: 17052816
[TBL] [Abstract][Full Text] [Related]
15. Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics.
Poolman J; Kriz P; Feron C; Di-Paolo E; Henckaerts I; Miseur A; Wauters D; Prymula R; Schuerman L
Vaccine; 2009 May; 27(24):3213-22. PubMed ID: 19446194
[TBL] [Abstract][Full Text] [Related]
16. Quantification of C-polysaccharide in Streptococcus pneumoniae polysaccharides by high-performance anion-exchange chromatography with pulsed amperometric detection.
Talaga P; Moreau M
Dev Biol (Basel); 2000; 103():27-34. PubMed ID: 11214250
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1*01 transgene: a model of SCID-hu mouse for vaccine development.
Camacho RE; Wnek R; Fischer P; Shah K; Zaller DM; Woods A; La Monica N; Aurisicchio L; Fitzgerald-Bocarsly P; Koo GC
Exp Hematol; 2007 Aug; 35(8):1219-30. PubMed ID: 17662890
[TBL] [Abstract][Full Text] [Related]
18. Active vaccination in patients with common variable immunodeficiency (CVID).
Goldacker S; Draeger R; Warnatz K; Huzly D; Salzer U; Thiel J; Eibel H; Schlesier M; Peter HH
Clin Immunol; 2007 Sep; 124(3):294-303. PubMed ID: 17602874
[TBL] [Abstract][Full Text] [Related]
19. Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults.
Lesprit P; Pédrono G; Molina JM; Goujard C; Girard PM; Sarrazin N; Katlama C; Yéni P; Morineau P; Delfraissy JF; Chêne G; Lévy Y;
AIDS; 2007 Nov; 21(18):2425-34. PubMed ID: 18025879
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal conjugate vaccines. A review.
Galiza EP; Heath PT
Minerva Med; 2007 Apr; 98(2):131-43. PubMed ID: 17519855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
